An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
One-hundred-seventy-nine lepromin-negative household contacts were vaccinated with heat-killed Mycobacterium leprae, BCG, or a combination of the two. Vaccination induced lepromin positivity in 131 of these contacts. Over an 8-year follow-up period, 12 lepromin-positive contacts developed leprosy, all tuberculoid; while 2 lepromin-negative vaccinated contacts developed leprosy, both lepromatous. Overall, 7.8% of the vaccinated contacts developed the disease. Seven-hundred-fourteen household contacts were not vaccinated, and served as controls. Among the 504 who were lepromin positive, leprosy developed in 35, all tuberculoid, over the 8-year follow up. Among the 210 lepromin-negative unvaccinated contacts, 61 developed leprosy: tuberculoid in 29, borderline in 4, lepromatous in 8, and indeterminate in 20. Overall, 13.5% of the 714 unvaccinated contacts and 29.0% of the 210 unvaccinated, lepromin-negative contacts developed leprosy. Vaccination could not induce lepromin positivity in all contacts. The three vaccines were equally effective in inducing lepromin positivity. Vaccination reduced the overall incidence of leprosy from 13.5% to 7.8% among household contacts but did not reduce the incidence of lepromatous leprosy (1.2% of all the vaccinated and 1.1% of all the unvaccinated contacts).
School of Tropical Medicine, Calcutta, India.
S
S
Chaudhury
S K
SK
Hazra
B
B
Saha
B
B
Mazumder
P C
PC
Biswas
D
D
Chattopadhya
K
K
Saha
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D001706:Biopsy; D002464:Cell Migration Inhibition; D004338:Drug Combinations; D005500:Follow-Up Studies; D006099:Granuloma / Q000473:pathology; D006801:Humans; D007194:India; D007918:Leprosy / Q000517:prevention & control*; D009166:Mycobacterium leprae / Q000276:immunology*; D012867:Skin / Q000473:pathology; D012882:Skin Tests; D014505:Urban Population
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D004338:Drug Combinations; C060596:anti-leprosy vaccine